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Abstract
Background: Concerns have been expressed regarding the adequacy of ethics review systems in developing 
countries. Limited data are available regarding the structural and functional status of Research Ethics Committees 
(RECs) in the Middle East. The purpose of this study was to survey the existing RECs in Egypt to better understand their 
functioning status, perceived resource needs, and challenges.
Methods: We distributed a self-administered survey tool to Egyptian RECs to collect information on the following 
domains: general characteristics of the REC, membership composition, ethics training, workload, process of ethics 
review, perceived challenges to effective functioning, and financial and material resources. We used basic descriptive 
statistics to evaluate the quantitative data.
Results: We obtained responses from 67% (12/18) of the identified RECs. Most RECs (10/12) have standard operating 
procedures and many (7/12) have established policies to manage conflicts of interests. The average membership was 
10.3 with a range from 7-19. The predominant member type was physicians (69.5% of all of the REC members) with 
little lay representation (13.7%). Most RECs met at least once/month and the average number of protocols reviewed 
per meeting was 3.8 with a range from 1-10. Almost three-quarters of the members from all of the 12 RECs indicated 
they received some formal training in ethics. Regarding resources, roughly half of the RECs have dedicated capital 
equipment (e.g., meeting room, computers, office furniture, etc); none of the RECs have a formal operating budget. 
Perceived challenges included the absence of national research ethics guidelines and national standards for RECs and 
lack of ongoing training of its members in research ethics.
Conclusion: Our study documents several areas of strengths and areas for improvements in the operations of Egyptian 
RECs. Regarding strengths, many of the existing RECs meet frequently, have a majority of members with prior training 
in research ethics, and have written policies. Regarding areas for improvements, many RECs should strive for a more 
diverse membership and should receive more financial resources and administrative support personnel. We 
recommend that RECs include more individuals from the community and develop a continuing educational program 
for its members. Institutional officials should be aware of the resource capacity needs of their RECs.
Background
Research involving human subjects has increased in vari-
ous regions in the developing world, including the Middle
East [1]. Concerns, however, have been expressed that the
intensification of research activities has not been accom-
panied by a corresponding increase in institutional
research ethics capacity, including functioning ethics
review systems [2-4]. Several studies have demonstrated
insufficient ethics capacity among investigators from the
different countries of the Eastern Mediterranean region
[5,6]. In general, commentators have voiced concerns that
research ethics committees (RECs) in developing coun-
tries might not be able to promote high standards of
human subject protection due to inadequate financial
and material resources, lack of adequately trained REC
members, insufficient diversity of membership, lack of
REC independence, and inability to monitor approved
protocols [2,7-9].
While the establishment of RECs in the Middle East has
recently increased, the quality and consistency of ethical
review remains unclear. Specifically, little data are avail-
able regarding processes of ethics review, member com-
position, training of members, workload and resource
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needs of RECs, and challenges that RECs encounter in
this region. In contrast, two studies have identified the
characteristics, resources and needs of RECs in Africa
[10,11]. Documenting the extent of the functional status
and capacity of existing RECs would be helpful in target-
ing areas for improvement and providing capacity build-
ing programs to meet the needs of these RECs. Such
information would also help guide policy makers (e.g.,
Ministry of Health and top officials at academic institu-
tions) and training programs in their support of strength-
ening of such committees. Accordingly, this survey study
was undertaken to better understand the operating char-
acteristics, status, and challenges of existing RECs in
Egypt.
Methods
Study Design
A cross-sectional survey study design.
Survey Tool
We adapted a survey tool used in a previous study assess-
ing resources and needs of research ethics committees in
Africa [10]. The completed survey tool contained the fol-
lowing domains of requested information: general char-
acteristics of the REC, membership composition, ethics
training, workload, process of ethics review, perceived
challenges to effective functioning, and financial and
material resources.
Participants
Chairs or their designee of known existing RECs in Egypt.
Recruitment and Distribution Process
We identified the existence of RECs in Egypt by conduct-
ing web searches, contacting REC members who
attended research ethics workshops in Egypt, searching
the list of registered RECs on the Office of Human
Research Protections (OHRP) website, and contacting
trainees of the Fogarty International Center/National
Institutes of Health (FIC/NIH) who are members of
Egyptian RECs [12].
We distributed the surveys to the chairpersons or their
designees of identified RECs between late 2007 and early
2008. Follow-up telephone calls were made to all contacts
to ensure they had received the survey. When requested,
the Egyptian principal investigator (HS) would visit the
chairperson to answer any questions about the survey.
Each respondent REC was sent a confidential copy of its
individual data superimposed on a summary result. This
served to verify the analysis and enabled each respondent
to compare his or her committee's responses relative to
the whole sample.
Statistical Analysis
We used basic descriptive statistics to present the quanti-
tative data.
Ethical Considerations
Informed Consent
A cover letter accompanied each survey containing infor-
mation about the purpose, risks, benefits, confidentiality,
contact information, and voluntary nature of the study.
Confidentiality
A code linking respondents to their surveys were kept
separately in a secure, locked, location. Confidentiality
was assured to enhance accurate reporting by the respon-
dents. We assured respondents that only aggregate data
would be described in public reports.
Ethics Review
This study was approved by the Research Ethics Commit-
tee at the National Hepatology and Tropical Medicine
Research Institute, Cairo, Egypt and the Institutional
Review Board at the University of Maryland, School of
Medicine, Baltimore, USA.
Results
We obtained responses from 67% (12/18) of the identified
RECs. Of these RECs, 7 were situated in academic institu-
tions, 4 in research institutions, and 1 in a non-govern-
mental organization (NGO).
General Characteristics
Table 1 shows the general characteristics of the respon-
dent RECs. All RECs reported being involved in the ethi-
cal review of research protocols. There were variable
responses regarding the specific types of researches that
they reviewed; for example, master thesis, doctoral thesis,
drug trials, and international studies. Most (10/12)
reported having written standard operating procedures
(SOPs), many (7/12) have established policies for disclo-
sure and management of potential conflicts of interest,
and half have a process whereby research participants can
register a complaint. RECs were asked to rate the appro-
priateness of a list of international ethical guidelines for
use in their review of research. Ratings were 'very appro-
priate', 'somewhat appropriate', 'not really appropriate',
and 'not inappropriate'. Guidelines rated by RECs as
being 'very appropriate' included the CIOMS guidelines
(64%); the Declaration of Helsinki (78%), and the IOMS
(56%). Only one REC rated the Belmont Report as "very
appropriate". RECs were asked to whom they reported
and 4 stated the Dean of their faculty, 4 reported to a top
official or an official person or body of the University
(President, Vice-President, Secretary General, or Faculty
Council of the Institution), 1 reported to the Department
Head, 1 reported to a high official of the NGO, and 2
stated 'none'.Sleem et al. BMC Medical Ethics 2010, 11:12
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Member Composition
The average number of members on the RECs was 10.3
members; median of 9 members and range of 7 to 19
members. All RECs had at least 7 members. Regarding
member type, 69.5% of the members from all of the RECs
were physicians, 8.5% were pharmacists, 4.8% were scien-
tists, 4.8% were lawyers, and 13.7% were individuals not
involved in medical, scientific, or legal work e.g., journal-
ist, ethicist, philosopher, religious leader, and community
member). In five RECs, more than 80% of the members
were physicians. In 9 RECs, there were members other
than someone involved from the medical, scientific, or
legal fields. Table 2 shows the numbers of RECs having at
least one member of the indicated profession. For exam-
ple, 92% of the RECs had at least one physician, whereas
50% of the RECs stated they had a community member
on their committee.
Workload
Of the RECs reporting their frequency of meetings (n =
11), 9 stated it met at least once/month, 1 met every 2
months, and 1 stated "other". The average duration of the
meetings of these 11 RECs was 2.0 hours (median: 2
hours; range 1-3). Of those who responded (n = 9), RECs
reviewed an average of 3.8 protocols per meeting
(median: 2.5, range 1 - 10) and an average of 42.3 proto-
cols per year (median: 22; range 1-150). Seven of the
RECs reported reviewing 5 or less protocols/meeting.
Continuing reviews and expedited reviews were per-
formed by 5 and 3 RECs, respectively.
Processes of Research Review
Table 3 shows aspects of the REC review process. Most of
the respondent RECs require investigators to use an REC-
submission form and most use a primary review system
in which all of these RECs attempt to match the subject
matter of the protocol to the primary reviewr's expertise.
Less than half of the RECs have in place a system whereby
the chair or a designated person can approve protocols by
an expedited system. Of these RECs, only one has actually
used such a system. Of the respondent RECs, 11 of 12
send written notification of its decision to the principal
investigator, but only six of these RECs state the expira-
tion date of its approval in the letter. Also, regarding the
approval letter, 8 of the RECs required investigators to
use the REC-approved informed consent forms, but only
7 of these RECs attach a copy of the consent form to the
approval letter. There was another REC that attached its
approved consent form to the approval letter, but did not
Table 2: Numbers of Research Ethics Committees with at 
least one of the listed professional type (n = 12)
Membership Category Category representation on the RECs
(% of RECs)
Medical Doctor 92% (11/12)
Pharmacist 42% (5/12)
Non-affiliated Doctor 33% (4/12)
Scientist 17% (2/12)
Nurse 8% (1/12)
Legal Expert 42% (5/12)
Journalist 25% (3/12)
Ethicist 17% (2/12)
Philosopher 8% (1/12)
Religious Leader 8% (1/12)
Administrator 8% (1/12)
Community Member 50% (6/12)
Table 1: Characteristics of Research Ethics Committees 
(n = 12)
Characteristic Frequency of RECs
Type of researches that are reviewed
Master's thesis 67% (8/12)
PhD thesis 75% (9/12)
Drug trials 73% (8/11)
International research 58% (7/12)
Existence of Standard Operating Procedures 83% (10/12)
Policies to manage conflicts of interest 58% (7/12)
Existence of a 'hot line' to received 
participants' complaints
50% (6/12)
Research ethics guidelines rated as 'very 
appropriate'*
CIOMS 64% (7/11)
Declaration of Helsinki 78% (7/9)
IOMS 56% (5/9)
Belmont Report 14% (1/7)
*Not all of the RECs gave a response to this itemSleem et al. BMC Medical Ethics 2010, 11:12
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explicitly state in the approval letter the requirement to
use it. Only 3 of these RECs stamped the informed con-
sent forms with the expiration date.
Perceived Capacity to Review Research and Training
RECs were asked to rate their perceived capacity to
review international protocols (capacity was not defined).
Of the 11 respondent RECs, 1 reported limited capacity, 3
reported moderate capacities, 6 reported good capacities,
and 1 reported it had excellent capacity.
Almost three-quarters (72.6%) of the members from all
the 12 RECs indicated they received some training in eth-
ics. Chairs from all of the RECs indicated that they had
received some prior ethics training. Respondent RECs
indicated that such training consisted of workshops (at
least 1/2 day workshop), and that 14.5% of all members
had received training from a FIC/NIH training initiative
[13]. Eleven RECs indicated that it has at least two mem-
bers with training in ethics. One REC indicated that none
of its members had received any training in research eth-
ics.
Table 4 shows how the respondent RECs rated the
importance of a list of training topics using the following
categories: 'very important', 'somewhat important', 'not
so important', and 'not important'. At least 90% of the
RECs considered the following topics to be either "very
imporant' or somewhat important': placebo controlled
trials; determination of methods to reduce risk; the inter-
pretation of pre-clinical studies; determination of risks in
research; assessment of benefits to participants and soci-
ety; scientific design issues in clinical trials; and monitor-
ing and oversight of approved studies. None of the listed
t o p i c s  w a s  c o n s i d e r e d  a s  " n o t  s o  i m p o r t a n t "  o r  " n o t
important" by more than 3 RECs.
Financial and Material Resources
None of the RECs reported having a budget, while 5
stated that their members receive financial compensation
for their activities. Regarding dedicated office space,
computer equipment, and secretarial support, 50% (6/
12), 58% (7/12), and 50% (6/12) of the RECs, respectively,
indicated that such resources were available to their com-
mittees. Other RECs reported having shared institutional
access to these resources. Finally, of the 12 RECs, 8 stated
that its chair performs administrative duties and 6 RECs
reported using a computerized database to track proto-
cols.
Challenges to Functioning
Table 5 shows the perceived challenges to REC function-
ing. Most of the reported challenges relate to a lack of
guidance from the national level in terms of research eth-
ics guidelines, standards for the operation of ethics com-
mittees, and an accreditation mechanism for RECs.
Other frequently mentioned challenges involve the
inability to monitor approved protocols, lack of ongoing
training for its members, and insufficient member com-
petence to review protocols.
Discussion
This survey of existing RECs in Egypt has identified
important operating structures, review processes, work-
loads, and financial and material resources of these com-
mittees. All of these characteristics can be considered as
important proxies for REC effectiveness, defined as
achieving the mandate to protect research participants.
This survey also shows that variability exists among the
respondent RECs regarding their functional characteris-
tics.
Table 3: Processes of Ethics Review (n = 12)
Review Process Response
Investigators are required to submit protocol 
using an REC submission form
58% (7/12)
A primary review system is used to review 
protocols
75% (9/12)
Attempt to match subject matter of protocol to 
primary reviewer's expertise
75% (9/12)
A system is in place whereby the chair or an 
authorized person is able to approve protocols 
by an expedited review process
42% (5/12)
Number of days that REC members have to 
review materials prior to meeting
<3 days (0/11)
3-7 days (4/11)
8-14 days (5/11)
>14 days (2/11)
REC notifies investigators in writing of its 
decision
92% (11/12)
Time interval between meeting and written 
notification to investigators
Average: 5.2 days
Median: 5
Range: 2-10 days
Contents of Approval Letter
For studies approved for 1 year, approval letter 
states expiration date
50% (6/12)
Requirement to use the REC-approved informed 
consent form
67% (8/12)
Copy of REC-approved consent form is attached 
to the approval letter
67% (8/12)
Attached REC-approved consent form is 
stamped with expiration date
25% (3/12)Sleem et al. BMC Medical Ethics 2010, 11:12
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Specifically, our survey shows that many of the RECs
have enabling characteristics needed for effective func-
tioning [4,14-17]. For example, regarding operational
structures and processes, most of the surveyed RECs
have SOPs and many have conflict of interest policies.
Also, all RECs report to high institutional officials, indi-
cating that their mandate comes from a high authority
that legitimizes its existence to their peers. It appears that
m a n y  a r e  a c t i v e ,  a s  m o s t  o f  t h e  R E C s  ( 9 / 1 1 )  r e p o r t e d
meeting at least once a month and are actively reviewing
protocols. The average duration of their meetings (2
hours) appears appropriate to the average number of pro-
tocols reviewed at each meeting (3.8 protocols/meeting).
Most of the RECs use international research ethics guide-
lines in their review of protocols and these included
CIOMS, IOMS, and the Declaration of Helsinki. In con-
trast, the Belmont Report is used sparingly, which is con-
sistent with surveys of RECs from other developing
regions [10,11]. This finding probably reflects that while
the Belmont Report serves as an important source of a
principled approach to the conduct of research in gen-
eral, its specification of the principles of research ethics is
limited in its scope and relevance for international
research.
Finally, many RECs adopt review processes recom-
mended by many authorities [14,17]. These processes
include sufficient time in advance of the meeting for
members to review the relevant documents, use of a pri-
mary review mechanism, attempts to match subject mat-
ter of the protocol to the primary reviewer's expertise,
and notification of investigators of its decisions in a
timely fashion and requirement that REC-approved con-
sent forms be used in the research. Finally, the number of
REC members with prior ethics training (approximately
75% of the current membership and 100% of the chairs) is
higher than that reported in previous surveys of RECs in
other developing countries [10,18]. To be sure, the target
goal of member training should be 100% to ensure that
"members have knowledge, skills, and abilities appropri-
ate to their respective roles" [19].
Our survey does demonstrate areas for improvement.
First, while our study indicates that most committees
exceed current minimum membership requirements in
terms of numbers, the diversity of membership appears
to be inadequate. Specifically, our survey showed that
there is a dominance of physicians/scientists on the exist-
ing RECs, as close to 88% of the members of the RECs
represented the scientific/medical/legal community. This
level exceeds international membership trends; for exam-
ple, a survey of 89 RECs in the United States in 2001
found that physicians, scientists and pharmacists
Table 4: Topics rated as being "very important" or "quite 
important".
Topics Percentage of RECs reporting
The use of placebo controlled 
trials
100% (10/10)
Determination of methods to 
reduce risk
92% (11/12)
The interpretation of pre-clinical 
studies
91% (10/11)
Determination of risks in research 91% (10/11)
Assessment of benefits to 
participants and society
90% (9/10)
Scientific design issues in clinical 
trials
90% (9/10)
Monitoring and oversight of 
approved studies
90% (9/10)
Assessment of cultural sensitivity 
for informed consent
82% (9/11)
Assessment of understanding of 
informed consent
80% (8/10)
Access to benefits after the trial is 
over
78% (7/9)
Determination of appropriate 
subject selection in vulnerable 
populations
75% (9/12)
Community participation 67% (6/9)
Social and behavioral studies 75% (9/12)
Privacy and confidentiality 70% (7/10)
Table 5: Challenges to proper functioning of the research 
ethics committees
Challenges Frequency of RECs reporting 
challenge
The need to develop appropriate 
national ethics guidelines
92% (11/12)
Inadequate ability to monitor 
approved protocols
91% (10/11)
Lack of ongoing training for 
members in research ethics
82% (9/11)
Lack of national accreditation 
mechanism for ethics committees
67% (8/12)
Lack of national standards for 
operation of committees
58% (7/12)
Competence of members to review 
research protocols
55% (6/11)
Variable use of ethical guidelines 
across committees in Egypt
33% (4/12)
Lack of coordination between 
different committee
33% (4/12)
Difficulties adapting international 
guidelines to local conditions
25% (3/12)Sleem et al. BMC Medical Ethics 2010, 11:12
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together made up 46% of REC membership [20]. Our sur-
vey results regarding member composition is similar to
what has been reported in other developing regions. For
e x a m p l e ,  i n  a  s u r v e y  c o n s i s t i n g  o f  1 2  R E C s  i n  S o u t h
Africa, doctors, scientists, and pharmacists together
made up 61% of the membership [11]. In another survey
of RECs in Southern Africa that reviewed HIV vaccine
trials, doctors, scientists, and nurses comprised 67% of
the membership [10].
Regarding members other than those in the medical,
scientific, or legal fields, only 9 RECs in our survey had at
least one of this member type and 5 of these RECs had
only one such member. Many guidelines recommend an
adequate diversity of membership. The Department of
H e a l t h  i n  S o u t h  A f r i c a  i s s u e d  n a t i o n a l  g u i d e l i n e s  t h a t
require RECs to be "representative of the communities
they serve and increasingly reflect the demographic pro-
file of the population of South Africa... [and that there
must be] "at least two lay persons with no affiliations with
the institution, not currently involved in medical, scien-
tific or legal work" [21]. The National Bioethics Advisory
Commission in the United States recommends that non-
scientists make up at least 25% of an REC membership
[22] and the United Kingdom requires that one third of
the REC membership be community members [23].
Membership diversity is considered important in carry-
ing out the REC charge of participant protection, as com-
munity members will be more knowledgeable and
sensitive to the concerns of those who participate in clini-
cal research. Critics have claimed that an imbalance in
membership in favor of researchers and other institu-
tional members biases the process towards the interests
of researchers versus the interest of research participants
[24]. Adding to the potential bias is that chairs are often
institutional scientists. Also, an REC that has a large pro-
portion of the membership consisting of affiliated scien-
tists/clinicians might hinder an objective and fair
discussion of the protocol being reviewed, as unaffiliated
members from the community might feel intimidated
from existing power differentials between themselves and
scientists/clinicians [24].
Having said this, a distinction needs to be made
between lay and community representation. Lay repre-
sentation often refers to individuals with no scientific or
medical background and hence, could include lawyers,
ethicists, priests, or theologians who have higher levels of
education than individuals from the communities being
researched and hence, might not be able to assess the
research from the perspective of those who actually par-
ticipate in the research. Community representatives, on
the other hand, would refer to non-professional, non-sci-
entific members who belong to the community that is
being researched and would more likely reflect the cul-
ture and values of the involved community [11]. These
issues of adequate community representation, however,
can often be clouded by ambiguity regarding how to
define the actual community, as well as who can serve as
the legitimate representatives of the communities.
F i n a l l y ,  m a n y  R E C s  r e p o r t e d  t h a t  t h e y  l a c k  e s s e n t i a l
financial and capital resources thought to be essential for
a well-functioning committee. For example, all of the
RECs operated without a budget and many were without
important dedicated office, computer, and secretarial
support. Also, three-quarters of the chairs were reported
to having to perform administrative duties. These find-
ings regarding financial and material resources are simi-
lar to those reported by RECs in South Africa [10,11].
RECs' challenges to effective functioning included a
lack of guidance at the national level. For example, they
cited the absence of national research ethics guidelines,
as well as the lack of national standards for RECs. Other
frequently mentioned challenges included lack of ongo-
ing training for its members, inability to monitor
approved protocols, and lack of a national accreditation
mechanism for ethics committees.
Many RECs also reported topics believed important for
their functioning and included placebo-controlled trials,
scientific design issues in clinical trials, determination of
risks and minimization of risks, assessment of benefits,
monitoring and oversight of approved studies, and
informed consent issues. The type of issues considered
important are similar to those reported by RECs in
Southern Africa [10,11].
Finally, it is important to note that our survey shows
variability among the respondent RECs in many of the
structural and operating processes, including member
composition, existence of written SOPs and conflict of
interest policies, access to adequate financial and material
resources, and processes of protocol review. The exis-
tence of variability in structure and processes probably
equates to variability in functioning between the different
RECs that might not offer a consistent protection mecha-
nism for research participants across the country. These
results strongly advocates the promotion of national
operating standards for RECs, as well as the establish-
ment of monitoring and oversight mechanisms for RECs,
including the institution of an accreditation process for
RECs. As a start, guidance can be given in the form of a
self-assessment tool that RECs can use to gauge its own
level of functioning.
There are several limitations to our study. First, the
responses were based on a process of self-report and
accordingly, there might have been a tendency to over
report the achievements of individual RECs as well as
underreport weaknesses. Second, the failure of other
existing RECs to complete the survey might represent an
element of bias to our aggregate results. Also, our results
for the 'high' level of members trained in research ethicsSleem et al. BMC Medical Ethics 2010, 11:12
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might be biased by the manner in which we identified the
RECs. For example, we identified REC members who had
attended research ethics workshops or those who had
attended a Fogarty-sponsored intensive training course in
research ethics. Another limitation of our survey was that
we failed to inquire about other types of information. For
example, we neglected to inquire about the gender com-
position of the individual RECs, as well as information
important in identifying challenges to the independence
of RECs. Finally, our results might not be generalizable to
other countries in the Middle East.
Notwithstanding these limitations, our survey docu-
ments several areas of strengths and areas for improve-
ments in the operations of RECs in Egypt. Regarding
s t r e n g t h s ,  m a n y  o f  t h e  R E C s  m e e t  f r e q u e n t l y ,  h a v e  a
majority of members with prior training in research eth-
ics, and have written policies, including those on SOPs
and conflicts of interest. Regarding areas for improve-
ments, many RECs should strive for a more diverse mem-
bership and should receive more financial resources and
administrative support personnel. Finally, most RECs
agree that the absence of national ethics guidelines and
ongoing training of their members represent challenges
for their functioning.
Conclusions
Our general recommendations include that RECs should
solicit individuals from the community to become mem-
bers and develop a continuing educational program for
its members. Institutional officials should be aware of the
resource capacity needs of the RECs in Egypt. Dialogue
should begin regarding the development of national
research ethics guidelines, national operating standards
for RECs, and the establishment of an accreditation
mechanism for RECs that can reduce variability among
the existing RECs.
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